{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalCondition"
  ],
  "@id": "health-sciences:medicine:cardiology:cardio-001",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:50:10.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "cardiology-knowledge-base"
    ],
    "confidence": 0.97,
    "status": "validated",
    "modified": "2026-01-11T14:20:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/cardiology",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "foundational",
    "aku_id": "001",
    "keywords": [
      "myocardial infarction",
      "heart attack",
      "acute coronary syndrome",
      "troponin",
      "ischemic heart disease",
      "coronary artery occlusion"
    ],
    "medical_specialty": "cardiology",
    "clinical_context": "acute_coronary_syndrome"
  },
  "content": {
    "title": "Myocardial Infarction Definition",
    "summary": "Acute necrosis of myocardial tissue due to prolonged ischemia, typically from coronary artery occlusion",
    "key_points": [
      "Type 1 MI: Atherothrombotic plaque rupture/erosion",
      "Type 2 MI: Oxygen supply-demand mismatch",
      "Type 3 MI: Sudden cardiac death with ischemic symptoms",
      "Type 4a/4b/5: Procedure-related MI (PCI/CABG)",
      "Troponin elevation required with rise/fall pattern",
      "Fourth Universal Definition is current standard"
    ],
    "statement": {
      "text": "Myocardial infarction (MI) is irreversible myocardial cell death due to prolonged ischemia, defined by detection of elevated cardiac biomarkers (preferably troponin) with rise and/or fall pattern plus at least one of: symptoms of acute myocardial ischemia, new ischemic ECG changes, development of pathological Q waves, imaging evidence of new loss of viable myocardium or regional wall motion abnormality in a pattern consistent with ischemic etiology.",
      "formal": "MI = Troponin rise/fall + (Symptoms OR ECG changes OR Q waves OR Imaging evidence of myocardial damage)"
    },
    "explanation": {
      "intuition": "A heart attack occurs when blood flow to part of the heart muscle is blocked long enough to cause irreversible cell death. The critical concept is 'time is muscle' - every minute of ischemia causes more myocardial damage. The heart muscle is exquisitely sensitive to oxygen deprivation because it cannot function anaerobically for long.",
      "key_insight": "The Fourth Universal Definition distinguishes 5 types of MI based on mechanism: atherothrombotic (Type 1) vs supply-demand mismatch (Type 2) have different treatments. Type 1 requires revascularization; Type 2 requires treating the underlying cause (e.g., anemia, tachyarrhythmia).",
      "technical_details": "Troponin must show a rise and/or fall pattern to distinguish acute MI from chronic troponin elevation (e.g., CKD, heart failure). The 99th percentile upper reference limit (URL) is the decision level. High-sensitivity troponin (hs-cTn) allows earlier detection (within 1-3 hours vs 6-12 hours for conventional troponin)."
    },
    "definitions_glossary": {
      "myocardial_infarction": "Irreversible death of heart muscle cells (cardiomyocytes) due to prolonged ischemia",
      "troponin": "Cardiac-specific regulatory protein (troponin I or T) released into bloodstream when myocardial cells die",
      "ischemia": "Insufficient blood supply to tissue resulting in oxygen deprivation",
      "atherothrombosis": "Thrombus formation on a ruptured or eroded atherosclerotic plaque",
      "plaque_rupture": "Disruption of fibrous cap covering atherosclerotic plaque, exposing thrombogenic lipid core",
      "supply_demand_mismatch": "Imbalance between myocardial oxygen delivery and consumption without acute coronary thrombosis",
      "pathological_Q_waves": "Deep Q waves (>1mm) indicating transmural myocardial necrosis",
      "regional_wall_motion_abnormality": "Segment of ventricular wall with reduced or absent contraction",
      "99th_percentile_URL": "Upper reference limit of troponin in healthy population, threshold for MI diagnosis",
      "high_sensitivity_troponin": "Assay capable of detecting troponin at very low concentrations in healthy individuals",
      "cardiomyocyte": "Individual heart muscle cell responsible for myocardial contraction",
      "transmural_infarction": "Full-thickness myocardial necrosis extending from endocardium to epicardium",
      "subendocardial_infarction": "Partial-thickness necrosis limited to inner myocardial layers"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Prolonged myocardial ischemia (typically >20-30 minutes) causes ATP depletion, calcium overload, membrane rupture, and cell death. Necrosis begins in subendocardium (most vulnerable to ischemia) and extends transmurally as ischemia duration increases ('wavefront phenomenon').",
      "cellular_events": [
        "0-20 min: Reversible ischemic injury (ATP depletion, anaerobic glycolysis)",
        "20-60 min: Irreversible injury begins, membrane integrity loss",
        "1-3 hours: Coagulative necrosis established",
        "3-6 hours: Troponin release detectable in blood",
        "6-12 hours: CK-MB elevation",
        "24-48 hours: Inflammatory cell infiltration",
        "1-2 weeks: Granulation tissue formation",
        "2-8 weeks: Scar formation complete"
      ],
      "wavefront_phenomenon": "Necrosis starts at subendocardium and progresses transmurally over time; early reperfusion can salvage epicardial myocardium"
    },
    "diagnostic_criteria": {
      "fourth_universal_definition": {
        "required": "Rise and/or fall of cardiac troponin with at least one value above 99th percentile URL",
        "plus_one_of": [
          "Symptoms of acute myocardial ischemia",
          "New ischemic ECG changes",
          "Development of pathological Q waves",
          "Imaging evidence of new loss of viable myocardium",
          "Intracoronary thrombus identified on angiography or autopsy"
        ]
      },
      "type_classification": {
        "type_1": "Atherothrombotic CAD with plaque rupture, erosion, or dissection",
        "type_2": "Oxygen supply-demand mismatch without acute coronary thrombosis",
        "type_3": "MI resulting in death when biomarkers unavailable",
        "type_4a": "MI related to PCI procedure",
        "type_4b": "MI related to stent thrombosis",
        "type_4c": "MI related to in-stent restenosis",
        "type_5": "MI related to CABG procedure"
      }
    },
    "treatment_options": {
      "acute_management": [
        "Dual antiplatelet therapy (aspirin + P2Y12 inhibitor)",
        "Anticoagulation (heparin or LMWH)",
        "Pain relief (morphine if needed)",
        "Supplemental oxygen (if SpO2 <90%)",
        "Beta-blocker (if no contraindications)",
        "ACE inhibitor/ARB (especially with LV dysfunction)",
        "Statin (high-intensity)"
      ],
      "reperfusion_therapy": {
        "PCI": "Primary PCI preferred for STEMI if door-to-balloon <90 min",
        "fibrinolysis": "Alternative for STEMI if PCI not available within 120 min",
        "CABG": "For left main disease, multivessel CAD, or failed PCI"
      },
      "secondary_prevention": [
        "Lifelong aspirin",
        "P2Y12 inhibitor for 12 months (minimum)",
        "High-intensity statin",
        "ACE inhibitor (especially if EF <40%)",
        "Beta-blocker (especially if EF <40%)",
        "Cardiac rehabilitation",
        "Lifestyle modifications (smoking cessation, diet, exercise)"
      ]
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Myocardial Infarction"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "Heart Attack"
      },
      {
        "@language": "en",
        "@value": "MI"
      },
      {
        "@language": "en",
        "@value": "Acute Myocardial Infarction"
      },
      {
        "@language": "en",
        "@value": "AMI"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Irreversible myocardial cell death due to prolonged ischemia, diagnosed by elevated cardiac biomarkers with rise/fall pattern plus clinical evidence of myocardial ischemia"
    },
    "notation": "cardio-001",
    "scopeNote": "Fourth Universal Definition (2018) is current standard; includes Type 1-5 classification",
    "example": "A 55-year-old male with crushing chest pain, diaphoresis, ST-elevation in leads V1-V4, and troponin I elevated to 5.2 ng/mL with serial rise"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "22298006",
      "uri": "http://snomed.info/id/22298006",
      "description": "Myocardial infarction (disorder)",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I21",
      "description": "Acute myocardial infarction",
      "matchType": "exactMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I21.0",
      "description": "ST elevation (STEMI) myocardial infarction of anterior wall",
      "matchType": "narrower"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I21.4",
      "description": "Non-ST elevation (NSTEMI) myocardial infarction",
      "matchType": "narrower"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D009203",
      "uri": "http://id.nlm.nih.gov/mesh/D009203",
      "description": "Myocardial Infarction",
      "matchType": "exactMatch"
    }
  ],
  "pedagogical": {
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "cardiology_fellows",
      "emergency_medicine_physicians",
      "nurse_practitioners"
    ],
    "estimated_time": "30min",
    "difficulty_curve": 0.65,
    "learning_objectives": [
      "Define myocardial infarction using the Fourth Universal Definition criteria",
      "Classify MI into Types 1-5 based on underlying mechanism",
      "Interpret troponin results including rise/fall pattern significance",
      "Differentiate Type 1 vs Type 2 MI for treatment decisions",
      "Describe the wavefront phenomenon of myocardial necrosis"
    ],
    "clinical_pearls": [
      "Type 2 MI treatment focuses on underlying cause, not revascularization",
      "Troponin rise/fall pattern distinguishes acute MI from chronic elevation (CKD, CHF)",
      "hs-cTnI can detect MI within 1-3 hours vs 6-12 hours for conventional troponin",
      "Door-to-balloon time <90 min is critical for STEMI outcomes",
      "Subendocardium dies first - early reperfusion saves epicardial muscle"
    ],
    "board_yield": {
      "usmle_step1": "High - pathophysiology of ischemic injury, troponin mechanism",
      "usmle_step2": "Very High - MI diagnosis, classification, treatment algorithm",
      "usmle_step3": "High - Type 1 vs Type 2 distinction, secondary prevention",
      "internal_medicine_boards": "Very High - acute management, complications, prognosis"
    },
    "common_misconceptions": [
      "All elevated troponins indicate MI (false - need rise/fall pattern + clinical context)",
      "Type 2 MI requires coronary intervention (false - treat underlying cause)",
      "Normal ECG excludes MI (false - posterior MI, early MI may have normal ECG)"
    ]
  },
  "relationships": {
    "prerequisites": [
      {
        "id": "urn:wskg:medicine:cardiology:coronary-artery-anatomy",
        "title": "Coronary Artery Anatomy",
        "strength": 0.95
      },
      {
        "id": "urn:wskg:medicine:cardiology:atherosclerosis-pathophysiology",
        "title": "Atherosclerosis Pathophysiology",
        "strength": 0.9
      }
    ],
    "skos:broader": [
      {
        "@id": "urn:wskg:medicine:cardiology:acute-coronary-syndrome",
        "@type": "skos:Concept",
        "skos:prefLabel": "Acute Coronary Syndrome"
      },
      {
        "@id": "urn:wskg:medicine:cardiology:ischemic-heart-disease",
        "@type": "skos:Concept",
        "skos:prefLabel": "Ischemic Heart Disease"
      }
    ],
    "skos:narrower": [
      {
        "@id": "health-sciences:medicine:cardiology:cardio-002",
        "@type": "skos:Concept",
        "skos:prefLabel": "STEMI Criteria"
      },
      {
        "@id": "health-sciences:medicine:cardiology:cardio-003",
        "@type": "skos:Concept",
        "skos:prefLabel": "NSTEMI Management"
      }
    ],
    "skos:related": [
      {
        "@id": "health-sciences:medicine:cardiology:cardio-047",
        "@type": "skos:Concept",
        "skos:prefLabel": "Acute Coronary Syndrome",
        "skos:note": "MI is a subset of ACS"
      },
      {
        "@id": "health-sciences:medicine:cardiology:cardio-048",
        "@type": "skos:Concept",
        "skos:prefLabel": "Cardiac Biomarkers",
        "skos:note": "Troponin is central to MI diagnosis"
      },
      {
        "@id": "health-sciences:medicine:cardiology:cardio-046",
        "@type": "skos:Concept",
        "skos:prefLabel": "Post-MI Complications",
        "skos:note": "Complications following myocardial infarction"
      }
    ],
    "owl:sameAs": [
      "http://snomed.info/id/22298006",
      "http://www.wikidata.org/entity/Q12152"
    ],
    "skos:exactMatch": [
      "http://snomed.info/id/22298006",
      "http://id.nlm.nih.gov/mesh/D009203"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T14:20:00.000Z",
    "sources": [
      {
        "source": "Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction. Circulation 2018;138:e618-e651",
        "type": "clinical_guideline",
        "year": 2018,
        "doi": "10.1161/CIR.0000000000000617",
        "confidence": 1.0,
        "relevance": "Definitive diagnostic criteria for MI"
      },
      {
        "source": "Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 12th ed. Elsevier 2022",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-0323722193",
        "confidence": 0.98,
        "relevance": "Comprehensive cardiology reference"
      },
      {
        "source": "Amsterdam EA, et al. 2014 AHA/ACC Guideline for NSTE-ACS. Circulation 2014;130:e344-e426",
        "type": "clinical_guideline",
        "year": 2014,
        "doi": "10.1161/CIR.0000000000000134",
        "confidence": 0.95,
        "relevance": "Treatment guidelines for NSTEMI"
      }
    ],
    "prov:wasDerivedFrom": [
      {
        "@id": "urn:source:fourth-universal-definition",
        "@type": "prov:Entity",
        "dc:title": "Fourth Universal Definition of Myocardial Infarction",
        "dc:type": "clinical_guideline",
        "confidence": 1.0
      }
    ]
  },
  "quality_assessment": {
    "CQS": 0.94,
    "completeness": 0.95,
    "accuracy": 0.97,
    "clarity": 0.93,
    "pedagogical_quality": 0.92,
    "ontology_alignment": 0.95,
    "last_assessment": "2026-01-11T14:20:00.000Z",
    "assessor": "quality-enhancement-agent"
  },
  "rendering_hints": {
    "primary_representation": "definition_with_classification",
    "show_images": true,
    "visualization": [
      "MI_type_classification_table",
      "wavefront_phenomenon_diagram",
      "troponin_rise_fall_curve",
      "coronary_anatomy_with_MI_territories"
    ],
    "emphasis": [
      "fourth_universal_definition_criteria",
      "type_1_vs_type_2_distinction",
      "troponin_interpretation"
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Myocardial_infarction",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q12152"
}